• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Sectors Health

NAFDAC alerts Nigerians to the recall of Brexafemme 150mg tablets

Chioma Chukwunedu by Chioma Chukwunedu
January 19, 2024
in Health, Sectors
NAFDAC

NAFDAC DG, Prof. Mojisola Adeyeye

Share on FacebookShare on TwitterShare on Linkedin

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public advisory regarding the voluntary nationwide recall of two lots of Brexafemme (ibrexafungerp tablets) 150 mg in the US market.

This action is being undertaken by Scynexis, Inc., following notification from the United States Food and Drug Administration (FDA).

The recall is prompted by the potential cross-contamination of the active ingredient used in the manufacturing process of Brexafemme tablets with a non-antibacterial ß-lactam drug substance.

RelatedStories

Steps to follow in getting a NAFDAC registration for your business in 2024

NAFDAC warns against counterfeit Herceptin cancer drug allegedly sourced from Nigeria, circulating in Ghana 

June 26, 2025
NAFDAC

NAFDAC DG urges pharma-academic collaboration to boost local drug, vaccine production 

May 11, 2025

Scynexis identified this risk during a review of manufacturing equipment and cleaning activities at one of its suppliers.

Why it matters

Brexafemme is an anti-fungal product prescribed for the treatment of vulvovaginal candidiasis (VVC) and the reduction of the incidence of recurrent vulvovaginal candidiasis (RVVC).

The potential risk associated with this recall is the cross-contamination with a non-antibacterial ß-lactam drug substance, which may lead to hypersensitivity reactions including swelling, rash, urticaria, and anaphylaxis—a potentially life-threatening adverse reaction.

Scynexis has not received any reports of adverse events linked to the possible beta-lactam cross-contamination to date.

Products details

NAFDAC noted that Brexafemme (ibrexafungerp tablets) 150 mg is not registered by NAFDAC. While the product is not found in the NAFDAC database, there is a possibility that it may have entered the country through informal markets.

NAFDAC urges importers, distributors, retailers, healthcare providers, and patients to exercise utmost caution and vigilance within the supply chain to prevent the importation, distribution, sale, or administration of falsified or substandard medicinal products.

All medical products should be sourced from authorized and licensed suppliers, with careful verification of authenticity and physical condition.

The agency strongly advises anyone in possession of the recalled product to not use it. Individuals who have used the product or experienced adverse reactions are urged to seek immediate medical advice from qualified healthcare professionals.

 


Follow us for Breaking News and Market Intelligence.
Tags: BrexafemmeNAFDAC
Chioma Chukwunedu

Chioma Chukwunedu

Chioma Chukwunedu is a pharmacist and health analyst. She uses data and articles to educate the public about healthcare services and systems so they can make informed decisions about their health.

Related Posts

Steps to follow in getting a NAFDAC registration for your business in 2024
Health

NAFDAC warns against counterfeit Herceptin cancer drug allegedly sourced from Nigeria, circulating in Ghana 

June 26, 2025
NAFDAC
Health

NAFDAC DG urges pharma-academic collaboration to boost local drug, vaccine production 

May 11, 2025
Over 25% of table water producers shut down in Ogun over multiple taxes, poor power supply – ATWAP  
Manufacturing

Over 25% of table water producers shut down in Ogun over multiple taxes, poor power supply – ATWAP  

March 24, 2025
Steps to follow in getting a NAFDAC registration for your business in 2024
Legal & Regulations

NAFDAC uncovers syndicate scamming foreign firms with fake documents

March 15, 2025
NAFDAC destroys N100 billion worth of illegal drugs seized from Idumota open drug market
Health

NAFDAC destroys N100 billion worth of illegal drugs seized from Idumota open drug market

March 9, 2025
NAFDAC shuts down over 240 factories producing adulterated products, seals Aba’s Cemetery market again 
Health

NAFDAC reopens Onitsha Market, seizes 50 truckloads of fake, substandard drugs

March 6, 2025
Next Post
Naira, Dollar

Forex turnover records $145.89 million as the naira depreciates marginally to N902.45/$1 at the official market  

Comments 1

  1. Abbas says:
    January 21, 2024 at 5:05 pm

    Nic one i Love thes newes

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank








DUNS

Recent News

  • Nigerian Ehis Akhimie convicted in US for $6 million fraud, faces up to 20 years in prison 
  • Tin Can Customs Command generates N747 billion in H1 2025, up 29.85% from last year
  • 9mobile, MTN to roll out National Roaming nationwide before end of July 

Follow us on social media:

Recent News

Nigerian Ehis Akhimie convicted in US for $6 million fraud, faces up to 20 years in prison 

Nigerian Ehis Akhimie convicted in US for $6 million fraud, faces up to 20 years in prison 

July 3, 2025
Nigerian Custom service

Tin Can Customs Command generates N747 billion in H1 2025, up 29.85% from last year

July 3, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics